Dinaciclib (SCH727965) 150x15mmDinaciclib (SCH727965) is a novel and potent CDK inhibitor for CDK2, CDK5, CDK1 and CDK9 with IC50 of 1 nM, 1 nM, 3 nM and 4 nM in cell free assays, respectively. It also blocks thymidine (dThd) DNA incorporation. Phase 3.
Capecitabine is a tumor-selective fluoropyrimidine carbamate
antifibrosis
NAD+ is a coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage
BIIB021 is an orally available
a humanized monoclonal antibody and the first in the class of agents called the HER2 dimerization inhibitors
TG101348) is a selective inhibitor of JAK2 with IC50 of 3 nM in cell-free assays
Corning (This is the suggested replacement for 2875-22 and 2895-22)These 22x22 square No
Extended databases of the 3Y series balance allow us to keep records of all acquired measurements
and 400- to 4000-fold more selectivity to p110
Gramine is a naturally occurring indole alkaloid present in several plant species
Bafetinib (INNO-406) is a potent and selective dual Bcr-Abl/Lyn inhibitor with IC50 of 5
Corning This PYREX® Friedrichs type condenser affords very efficient operation
